no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features
|
Possidente, Luciana |
|
2017 |
34 |
5 |
p. 1-7 |
article |
2 |
Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy
|
Inui, Naoki |
|
2017 |
34 |
5 |
p. 1-11 |
article |
3 |
A statistical issue regarding the original paper by M. Tamiya and others (Med Oncol (2016) 33:2 DOI 10.1007/s12032-015-0715-7)
|
Yoshioka, Hiroshige |
|
2017 |
34 |
5 |
p. 1 |
article |
4 |
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer
|
Kusaka, Ayumu |
|
2017 |
34 |
5 |
p. 1-10 |
article |
5 |
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor
|
Wiechno, Paweł J. |
|
2017 |
34 |
5 |
p. 1-8 |
article |
6 |
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
|
Menderes, Gulden |
|
2017 |
34 |
5 |
p. 1-8 |
article |
7 |
Erratum to: Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization
|
Scevola, Germano |
|
2017 |
34 |
5 |
p. 1-3 |
article |
8 |
Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma
|
Pang, Zhaofei |
|
2017 |
34 |
5 |
p. 1-9 |
article |
9 |
Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology
|
Alterio, D. |
|
2017 |
34 |
5 |
p. 1-10 |
article |
10 |
Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer
|
Zhang, Liang |
|
2017 |
34 |
5 |
p. 1-8 |
article |
11 |
LincRNa-p21: function and mechanism in cancer
|
Chen, Shaoyun |
|
2017 |
34 |
5 |
p. 1-8 |
article |
12 |
Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications
|
Ierardi, Anna Maria |
|
2017 |
34 |
5 |
p. 1-9 |
article |
13 |
Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients
|
Bhandari, Prerana |
|
2017 |
34 |
5 |
p. 1-9 |
article |
14 |
Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis
|
D’Angelo, Francesco |
|
2017 |
34 |
5 |
p. 1-8 |
article |
15 |
9p24 abnormalities in hematologic malignancies with a focus on diffuse large B-cell lymphoma
|
Patel, Dilan A. |
|
2017 |
34 |
5 |
p. 1-2 |
article |
16 |
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?
|
Erlmeier, Franziska |
|
2017 |
34 |
5 |
p. 1-6 |
article |
17 |
Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma
|
Zhang, Bo |
|
2017 |
34 |
5 |
p. 1-9 |
article |
18 |
Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer
|
Franco, Pierfrancesco |
|
2017 |
34 |
5 |
p. 1-8 |
article |
19 |
Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial
|
Macchi, M. |
|
2017 |
34 |
5 |
p. 1-10 |
article |
20 |
Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices
|
Herring, Maurice |
|
2017 |
34 |
5 |
p. 1-11 |
article |
21 |
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
|
Meattini, Icro |
|
2017 |
34 |
5 |
p. 1-6 |
article |
22 |
Systematic review: isocaloric ketogenic dietary regimes for cancer patients
|
Erickson, N. |
|
2017 |
34 |
5 |
p. 1-13 |
article |
23 |
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature
|
Meattini, Icro |
|
2017 |
34 |
5 |
p. 1-8 |
article |
24 |
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms
|
Chang, Yu-Cheng |
|
2017 |
34 |
5 |
p. 1-6 |
article |
25 |
Targeting TDO in cancer immunotherapy
|
Yu, Cheng-Peng |
|
2017 |
34 |
5 |
p. 1-9 |
article |
26 |
Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer
|
Colloca, Giuseppe |
|
2017 |
34 |
5 |
p. 1-9 |
article |
27 |
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset
|
Plotti, Francesco |
|
2017 |
34 |
5 |
p. 1-5 |
article |
28 |
Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies
|
Reginelli, Alfonso |
|
2017 |
34 |
5 |
p. 1-8 |
article |